A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy

International Journal of Cardiology

Volumn 197, Issue , 2015, Pages 294-295

  Fan, Zhixing ^a   Yang, Chaojun ^a   Yang, Jian ^a  

^a CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; CONGESTIVE HEART FAILURE; DIABETIC CARDIOMYOPATHY; DRUG EFFICACY; GLUCAGON RELEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HORMONE INHIBITION; HUMAN; LETTER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; BLOOD; DIABETIC CARDIOMYOPATHIES; GLUCOSE BLOOD LEVEL; METABOLISM;

BIOMARKERS; BLOOD GLUCOSE; DIABETIC CARDIOMYOPATHIES; GLUCAGON-LIKE PEPTIDE 1; HUMANS;

EID: 84938529659     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.108     Document Type: Article

References (14)

1. Y. Xu, L. Wang, J. He, and et al. Prevalence and control of diabetes in Chinese adults JAMA 310 9 2013 948 959
2. H. Bugger, and E.D. Abel Molecular mechanisms of diabetic cardiomyopathy Diabetologia 57 4 2014 660 671
3. H. Suzuki, Y. Kayama, M. Sakamoto, and et al. Arachidonate12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy Diabetes 64 2 2015 618 630
4. A.R. Meloni, M.B. DeYoung, C. Lowe, and et al. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence Diabetes Obes. Metab. 15 1 2013 15 27
5. T. Sato, H. Hayashi, M. Hiratsuka, and et al. Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells Mol. Cell. Endocrinol. 406 5 2015 60 67
6. P. Grant, D. Lipscomb, and J. Quin Psychological and quality of life changes in patients using GLP-1 analogues J. Diabetes Complicat. 25 4 2011 244 246
7. C.C. Ronveaux, D. Tomé, and H.E. Raybould Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling J. Nutr. 145 4 2015 672 680
8. J.E. Richard, R.H. Anderberg, A. Göteson, and et al. Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system PLoS One 10 3 2015 e0119034
9. A. Shiraki, J. Oyama, H. Komoda, and et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells Atherosclerosis 221 2 2012 375 382
10. X. Hu, X. Yang, and H. Jiang Glucagon-like peptide-1 and related agents: novel anti-arrhythmic agents during myocardial ischemia and reperfusion Int. J. Cardiol. 168 3 2013 3119 3120
11. M. Yin, B.D. Westenbrink, M. Meissner, and et al. Variable effects of anti-diabetic drugs in animal models of myocardial ischemia and remodeling: a translational perspective for the cardiologist Int. J. Cardiol. 169 6 2013 385 393
12. D. Wang, P. Luo, Y. Wang, and et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism Diabetes 62 5 2013 1697 1708
13. R. de Jong, G.P. van Hout, J.H. Houtgraaf, and et al. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction Circ. Cardiovasc. Interv. 7 5 2014 673 683
14. J. Lonborg, N. Vejlstrup, H. Kelbaek, and et al. Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment:results from a randomized study Diabetes 63 7 2014 2474 2485